| Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial | 
|---|---|
| Contact name | Lada Beara-Lasic | 
| Contact phone | 919-541-8979 | 
| Contact email | Lada.Beara-Lasic@va.gov | 
| PI name | John Lieske | 
| Owner | Lada Beara Lasic | 
| Institution | Mayo Clinic |